Speeding Targeted Therapies Drug Discovery


Eudendron is an Oncology Drug Discovery company focused on the development of a new generation of Kinase Inhibitors for Targeted Therapies. 


Eudendron has developed novel molecular designs to generate compounds successfully inhibiting kinase mutated forms


Eudendron S.r.l.

Legal Office:

Via Dei Carantani,1 


21100 - ITALY


P.IVA: 03303730125 

C.F.: 03303730125

REA: VA-340127


T: +39 340 3665660

    +44 7918 928462

© 2012 by Eudendron Srl. 

No animals were harmed in the making of this site.

  • facebook
  • w-tbird
  • w-googleplus
This site was designed with the
website builder. Create your website today.
Start Now